The "Thin-Fat" Indian Phenomenon
India has a unique and dangerous metabolic pattern: even at normal BMIs, Indians tend to accumulate visceral fat — the deep abdominal fat that wraps around your organs. This "thin-fat" phenotype is why Indian men with a 34-inch waist and seemingly normal weight can have the metabolic profile of an obese person in Western countries.
90 cm
Risk waist (Indian men) vs 102cm Western
80 cm
Risk waist (Indian women) vs 88cm Western
Why Visceral Fat Is More Dangerous Than Subcutaneous Fat
Subcutaneous fat (the fat you can pinch) is largely cosmetic. Visceral fat is metabolically active — it produces inflammatory chemicals, disrupts insulin signalling, raises blood pressure, and dramatically increases your risk of heart disease, diabetes, and fatty liver disease. India's high rates of premature heart attacks are directly linked to visceral fat accumulation.
How GLP-1 Medications Target Visceral Fat
Research shows GLP-1 medications preferentially reduce visceral fat over subcutaneous fat. In clinical trials, patients on semaglutide lost 30–40% more visceral fat than patients on diet alone. This makes GLP-1 particularly relevant for Indians, who accumulate visceral fat disproportionately.
MetaFit's Visceral Fat Protocol
We measure waist circumference and waist-to-hip ratio as core metrics — not just weight and BMI. Because a patient who loses 5 kg of visceral fat has achieved something far more medically significant than someone who lost 10 kg of water weight. We track what matters for your actual health, not just the number on a scale.
Ready to Start Your Weight Loss Journey?
Get a personalized medical assessment from MetaFit's expert doctors — tailored for the Indian lifestyle.
Book a Free ConsultationOr download the app to get started